The tertiary hospital issued a set of adopted drug assessment indicators: the proportion of use, the proportion of completion!

The 2022 version of the assessment indicators for tertiary public hospitals has been released recently
.
It is worth noting that, in addition to the assessment of the use ratio of the selected varieties in the country, this edition also adds a completion ratio assessment
.
Although there have been requirements for the proportion of domestically sourced medicines in various places in the past two years, there are few clear requirements for the completion ratio.
With the introduction of the new version of the assessment indicators, these two indicators will also be implemented in local hospitals in the future
.
Recently, the General Office of the National Health and Medical Commission issued the "Notice on Printing and Distributing the Performance Assessment Operation Manual of National Tertiary Public Hospitals (2022 Edition)", with a total of 56 performance assessment indicators and a total score of 560 points
.
Among them, there is an indicator related to the use of drugs in national centralized procurement, and there is also an extended indicator: [Completion ratio of selected drugs in national centralized procurement], which is the assessment indicator added in this edition of the manual
.
This indicator mainly evaluates the proportion of successful bids and selected drugs in the centralized procurement of drugs organized by the state in the year
.
This extended indicator: the numerator is the number of varieties of the selected drugs that the hospital has completed the centralized procurement of drugs organized by the state in the purchase and sales contracts with volume
.
The denominator is the number of varieties of the selected drugs that the hospital should complete the centralized procurement of drugs organized by the state in the purchase and sale contracts with volume
.
The selected drugs for which the purchase and sales contracts with volume have not expired are not included in the assessment of this extended index
.
Previously, the "Guiding Opinions of the General Office of the State Council on Improving the Centralized Procurement of Medicines in Public Hospitals" (Guobanfa [2015] No.
7) clarified that all medicines (excluding Chinese herbal medicines) used in hospitals should pass the provincial centralized medicine procurement platform.
Procurement
.
The "Operation Manual (2022 Edition)" clarifies that strengthening the use of assessment results aims to urge medical institutions to continuously improve their work and improve the level of rational drug use based on the problems found in the assessment
.
Local health administrative departments at all levels should incorporate the results of rational drug use assessment into the performance assessment of medical institutions, and combine them with medical institution verification, hospital review, and evaluation.

.
In 2020, the use of selected drugs from the national procurement in public hospitals has clearly increased compared with previous years.
According to the content of the regular policy briefing held by the State Council Information Office on February 11, 2022, the National Health and Health Commission, in the work of centralized procurement of drugs and medical consumables, In terms of instructing medical institutions on how to prioritize and rationally use drugs, a number of documents have been issued to guide medical institutions to prioritize and rationally allocate and use the drugs that have won the national centralized procurement to ensure the implementation of this work
.
In 2020, the monitoring data of drug use in public hospitals shows that about 33,795 of all second- and third-level public hospitals and 55% of the primary medical and health institutions in the country will be given priority to use the first batch and second batch of the national centralized procurement of winning drugs
.
The above-mentioned medical institutions completed 227.
1% of the agreed purchase volume of the national batch of selected drugs, accounting for 79.
1% of the use of the 25 drug varieties in the same year, and completed 168.
9% of the agreed purchase volume of the second batch, accounting for the total use of the 32 drugs in the same year.
63.
6% of the amount
.
The monitoring data also showed that the use of the above-mentioned hospitals in a batch of national centralized procurement of the winning drugs increased by 129.
7%, 143.
3% and 188.
6% respectively compared with 2018, and the use of the second batch increased by 114.
9%, 130% and 135.
4% compared with 2019
.
This data shows that the use of selected drugs, especially in primary medical and health institutions, has greatly increased compared with that before the national centralized procurement
.
The rational drug use document focuses on the allocation and use of the selected drugs in the country, and the proportion of completion will also be concerned.
Previously (December 20, 2019), the General Office of the National Health and Health Commission issued the "About Doing a Good Job in the Assessment of Rational Drug Use in Medical Institutions" Notice (Guoweiban Medical Letter [2019] No.
903), special management drugs such as poison, anesthesia, semen, and prophylaxis in medical institutions, key monitoring varieties such as antibacterial drugs, national essential drugs, drugs purchased by the state with quantity, and national medical insurance negotiation The equipment and use of varieties are included in the assessment of rational drug use
.
The issuance of this document also marks that the reform of rational drug use has officially entered the implementation stage in medical institutions
.
At present, many provinces have issued relevant landing documents
.
On October 26, 2020, the official website of the Chongqing Municipal Health and Health Commission posted a notice for public consultation on the "Chongqing Medical Institutions Rational Drug Use Assessment Work Plan (Draft for Comment)".
In addition to the requirements for the use, monitoring of key drugs, and the use of centrally collected drugs, the standard requirements for the use and management of anti-tumor drugs and the development of therapeutic drug monitoring (TDM) are also specifically clarified
.
In November 2021, the Anhui Provincial Health and Health Commission issued the "Notice on Printing and Distributing the Work Plan for the Evaluation of Rational Drug Use in Medical Institutions in Anhui Province", which will evaluate 11 first-level indicators of medical institutions, including special management drugs, anti-tumor drugs, The use and management of anti-tumor drugs, key monitoring drugs, intravenous infusions, and the equipment and use of basic drugs, nationally selected drugs, and nationally negotiated drugs are all included in the assessment scope
.
However, on December 14, 2021, 40 hospitals in the Tibet Autonomous Region were notified because the proportion of the third batch of national procurement was 0
.
The Tibet Medical Insurance Bureau stated that in the future, the reporting volume and contract performance will be included in the comprehensive evaluation, and linked to relevant indicators such as fund allocation
.
If the situation is serious, the disciplinary inspection and supervision departments will be jointly interviewed and held accountable
.
This shows that the proportion of selected drugs selected in the country will also be gradually paid attention to
.